Pricing Log in Create free account
Saturday 17 October 2026 Export IQV’s income statement to Excel — free account

IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

266.90 4.14 −1.53%
Market cap
$44.6B
P/E
32.8×
Fwd P/E
22.3×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

IQVIA Holdings Inc. (IQV) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, IQVIA Holdings Inc. (IQV) trades at a EV/Sales of 3.4×. Over the past ten years it has ranged from 1.5× (February 2016) to 4.8× (December 2021); the current reading is higher than 55% of that period. That is below the Diagnostics & Research industry median of 5.5× and in line with the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 3.2× 3.47%
FY2024 3.1× (14.78%)
FY2023 3.6× 5.54%
FY2022 3.4× (26.01%)
FY2021 4.7× 17.87%
FY2020 4.0× 7.20%
FY2019 3.7× 13.83%
FY2018 3.2× 1.57%
FY2017 3.2× 24.70%
FY2016 2.6× 47.69%

Quarterly newest first

Period EV/Sales Change
Jun 2026 2.7× 6.16%
Mar 2026 2.6× (20.46%)
Dec 2025 3.2× 12.61%
Sep 2025 2.8× 10.79%
42 more quarters

Against its own ten years

Low 1.5× High 4.8×
Ten-year median 3.4×
Current reading's percentile 51

EV/Sales against peers

Company EV/Sales
LH Labcorp Holdings Inc. compare 2.2×
DGX Quest Diagnostics Incorporated compare 2.7×
IQV IQVIA Holdings Inc. 3.4×
A Agilent Technologies, Inc. compare 6.9×
MTD Mettler-Toledo International, Inc. compare 8.4×
ILMN Illumina, Inc. compare 9.0×
IDXX IDEXX Laboratories, Inc. compare 9.8×
WAT Waters Corporation compare 10.2×
NTRA Natera, Inc. compare 20.5×
Diagnostics & Research industry median 5.5×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on IQV